Genome-scale signatures of gene interaction from compound screens predict clinical efficacy of targeted cancer therapies. Date: March 30th, 2018 Speaker: Dr. Peng Jiang, Shirley Liu Lab at Dana Farber Cancer Institute and Harvard School of Public Health. Video: https://youtu.be/9I8l5fP_dtw Presentation: Download
@Dahshu 2020